Status | Study |
Recruiting |
Study Name: MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b Condition: Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Date: 2016-06-20 Interventions: Drug: Combination of Lopinavir /Ritonavir and Interferon beta-1b |
Active, not recruiting |
Study Name: Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults Condition: Middle East Respiratory Syndrome Coronavirus Date: 2016-05-28 Interventions: Biological: SAB-301 SAB-301 is |
Completed |
Study Name: Saudi Outcomes of ECMO-treated MERS-CoV Patients Condition: MERS-CoV Infection Refractory Hypoxemia Date: 2015-12-04 Interventions: Other: Extracorporeal Membrane Oxygenation |
Completed |
Study Name: Seroprevalence of MERS-CoV IgG in Healthcare Workers Condition: Coronavirus Infections Date: 2015-07-06 |
Withdrawn |
Study Name: Phase I Dose Escalation SARS-CoV Recombinant S Protein, With and Without Adjuvant, Vaccine Study Condition: SARS Date: 2011-06-16 Interventions: Drug: Aluminum hydroxide adjuvant (Alhydrogel®) |
Completed |
Study Name: Collection and Testing of Respiratory Samples Condition: QIAGEN ResPlex II Advanced Panel Influenza A Respiratory S Date: 2011-02-18 Interventions: Device: artus Influenza A/B RT-PCR Test The investigational assay, used for detecting the presence of In |
Active, not recruiting |
Study Name: The Respiratory Protection Effectiveness Clinical Trial Condition: Influenza Respiratory Syncytial Viruses Paramyxoviridae In Date: 2010-11-29 Interventions: Device: N95 Respirator Partici |
Recruiting |
Study Name: Respiratory Virus Hospitalization Study (FLU 003 Plus) Condition: Influenza Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-Co Date: 2010-01-25 |
Active, not recruiting |
Study Name: A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome Condition: Severe Acute Respiratory Syndrome Date: 2007-12-20 Interventions: Drug: Lopinavir / Ritonavir plus Ribavirin |
Withdrawn |
Study Name: SARS Coronavirus Vaccine (SARS-CoV) Condition: Coronavirus (SARS-CoV) Date: 2007-09-20 Interventions: Drug: Aluminum hydroxide Adjuv |